Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?
- PMID: 24839974
- DOI: 10.1038/nrcardio.2014.70
Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?
Comment in
-
Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.Nat Rev Cardiol. 2014 Nov;11(11):638. doi: 10.1038/nrcardio.2014.70-c2. Epub 2014 Sep 30. Nat Rev Cardiol. 2014. PMID: 25267421 No abstract available.
-
Ethnicity and sympathetic tone: predictors of the blood pressure response to renal denervation?Nat Rev Cardiol. 2014 Nov;11(11):638. doi: 10.1038/nrcardio.2014.70-c1. Epub 2014 Sep 30. Nat Rev Cardiol. 2014. PMID: 25267424 No abstract available.
Similar articles
-
Resistant hypertension and renal denervation. Considerations on the results of the SYMPLICITY HTN-3 trial.Rev Esp Cardiol (Engl Ed). 2014 Nov;67(11):881-2. doi: 10.1016/j.rec.2014.06.017. Epub 2014 Sep 18. Rev Esp Cardiol (Engl Ed). 2014. PMID: 25242659 No abstract available.
-
SYMPLICITY HTN-3 trial: what is it and what does it mean?Eur Heart J. 2014 Jul;35(26):1697-8. Eur Heart J. 2014. PMID: 25152948 No abstract available.
-
Renal sympathetic denervation in the aftermath of Symplicity HTN-3.Blood Press. 2014 Oct;23(5):256-61. doi: 10.3109/08037051.2014.953861. Blood Press. 2014. PMID: 25212427 Review. No abstract available.
-
Was there real denervation in the SYMPLICITY HTN-3 trial?Eur Heart J. 2014 Jul;35(26):1699-1700. Eur Heart J. 2014. PMID: 25152949 No abstract available.
-
Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?Can J Cardiol. 2015 May;31(5):642-8. doi: 10.1016/j.cjca.2014.12.004. Epub 2014 Dec 11. Can J Cardiol. 2015. PMID: 25828371 Review.
Cited by
-
Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.J Am Heart Assoc. 2015 Mar 23;4(3):e001415. doi: 10.1161/JAHA.114.001415. J Am Heart Assoc. 2015. PMID: 25801757 Free PMC article. Review. No abstract available.
-
Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.Front Physiol. 2015 Feb 9;6:9. doi: 10.3389/fphys.2015.00009. eCollection 2015. Front Physiol. 2015. PMID: 25709581 Free PMC article. Review.
-
Where and when device therapy may be useful in the management of drug-resistant hypertension.Curr Cardiol Rep. 2014 Nov;16(11):546. doi: 10.1007/s11886-014-0546-8. Curr Cardiol Rep. 2014. PMID: 25326400 Review.
-
Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence.Eur Cardiol. 2014 Dec;9(2):110-114. doi: 10.15420/ecr.2014.9.2.110. Eur Cardiol. 2014. PMID: 30310496 Free PMC article. Review.
-
Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.Nat Rev Cardiol. 2014 Nov;11(11):638. doi: 10.1038/nrcardio.2014.70-c2. Epub 2014 Sep 30. Nat Rev Cardiol. 2014. PMID: 25267421 No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical